Parasite Viability as a Measure of In Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment.
Antimicrob Agents Chemother
; 66(7): e0011422, 2022 07 19.
Article
in En
| MEDLINE
| ID: mdl-35727057
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Parasites
/
Malaria, Falciparum
/
Artemisinins
/
Antimalarials
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Country/Region as subject:
Oceania
Language:
En
Year:
2022
Type:
Article